Text this: WCN25-3408 FIRST-AND SECOND-LINE THERAPY OF ZUBERITAMAB IN IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SINGLE-CENTER RETROSPECTIVE STUDY